Details

Last Funding Type

Series B

Last Funding Money Raised

£26.30M

Industries

Health Care,Nutrition,Personal Health,Wellness

Founded date

Aug 1, 2015

Number Of Employee

51 - 100

Operating Status

Active

Legal Name

DayTwo Inc.

Also Known As

DayTwo

DayTwo is a precision nutrition company that uses food as medicine to enable a path to remission for metabolic diseases including diabetes, prediabetes, clinical obesity, NAFLD.

DayTwo's groundbreaking scientific discovery, published in CELL (2015) and JAMA (2019) determined that people respond differently to the same food, thus knowing what food “works” for each person is crucial to an effective care plan.

DayTwo uses gut microbiome sequencing (stool sample, akin to Cologuard) to create Food Prescriptions™ for each patient which balance blood sugar levels, improve energy, manage hunger, and help members lose weight.

The DayTwo virtual care solution is delivered through Certified Diabetes Care and Education Specialists and Registered Dietitians using a digital app to track progress and to communicate with members.
DayTwo uses A1C and Time In Range as the primary clinical outcomes, and weight as a secondary outcome. For those who implement the DayTwo protocol, DayTwo offers up to 100% fees-at-risk.